Consulting Agreements
All Business Industries
REXAHN PHARMACEUTICALS, INC. (181) | Consulting Agreements (4)
- Interim President and CEO Consulting Letter Agreement by and between Ocuphire Pharma, Inc. and Richard Rodgers, dated April 20, 2023 (Filed With SEC on May 15, 2023)
- First Amendment to the Consulting Agreement dated September 19, 2022, by and between the Company and Jay Pepose (Filed With SEC on March 30, 2023)
- Second Amendment to the Consulting Agreement dated December 1, 2022, by and between the Company and Jay Pepose (Filed With SEC on March 30, 2023)
- Consulting Agreement between the Registrant and Jay Pepose dated April 8, 2022 (Filed With SEC on May 13, 2022)